Why the study?
What is the efficacy and safety of loop diuretics and ultrafiltration in heart failure?
Population
Patients with congestive heart failure (HF) and acute decompensated HF
Design
Review
Authors
Loading...
Highlights gaps in HF decongestion guidance; leaves open prospective validation of biomarker-based algorithms.
What is the efficacy and safety of loop diuretics and ultrafiltration in heart failure?
There is an unmet need for evidence-based algorithms incorporating biomarkers to optimize decongestion therapies in heart failure.
Rossignol et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: